Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000905148-25-000864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-03 | ATRA | Hyllengren Eric J | EVP, CFO, COO | S - Sale | $7.00 | -1,211 | 56.2K | -2% | -$8,477 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 1,211 | $7.00 | 56,231 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |